Tower Research Capital LLC (TRC) - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALTW and the CUSIP is 363225111. A total of 5 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$01330.0%0.00%
Q3 2016$01330.0%0.00%
Q2 2016$01330.0%0.00%
Q1 2016$01330.0%0.00%
Q4 2015$0133
-29.6%
0.00%
Q3 2015$01890.0%0.00%
Q2 2015$0
-100.0%
189
-81.9%
0.00%
Q1 2015$1,0001,045
+261.6%
0.00%
Q4 2014$0
-100.0%
289
-67.5%
0.00%
Q3 2014$2,000
-66.7%
889
+38.9%
0.00%
-100.0%
Q2 2014$6,000
-25.0%
640
-13.5%
0.00%0.0%
Q1 2014$8,000
-20.0%
740
-64.2%
0.00%
-50.0%
Q4 2013$10,000
+150.0%
2,068
+208.7%
0.00%
Q3 2013$4,000
+300.0%
670
-10.7%
0.00%
Q2 2013$1,0007500.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 643,800$1,461,0000.00%
Neuberger Berman Group LLC 129,700$294,0000.00%
Tower Research Capital LLC (TRC) 889$2,0000.00%
UBS AG 1,355$3,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders